Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2006 3
2007 2
2009 5
2010 3
2011 5
2012 11
2013 18
2014 13
2015 15
2016 11
2017 7
2018 11
2019 11
2020 20
2021 24
2022 9
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

152 results

Results by year

Filters applied: . Clear all
Page 1
Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study.
Girard N, Bar J, Garrido P, Garassino MC, McDonald F, Mornex F, Filippi AR, Smit HJM, Peters S, Field JK, Christoph DC, Sibille A, Fietkau R, Haakensen VD, Chouaid C, Markman B, Hiltermann TJN, Taus A, Sawyer W, Allen A, Chander P, Licour M, Solomon B. Girard N, et al. Among authors: filippi ar. J Thorac Oncol. 2023 Feb;18(2):181-193. doi: 10.1016/j.jtho.2022.10.003. Epub 2022 Oct 25. J Thorac Oncol. 2023. PMID: 36307040 Free article.
Whey protein isolate supplementation improves body composition, muscle strength, and treatment tolerance in malnourished advanced cancer patients undergoing chemotherapy.
Cereda E, Turri A, Klersy C, Cappello S, Ferrari A, Filippi AR, Brugnatelli S, Caraccia M, Chiellino S, Borioli V, Monaco T, Stella GM, Arcaini L, Benazzo M, Grugnetti G, Pedrazzoli P, Caccialanza R. Cereda E, et al. Cancer Med. 2019 Nov;8(16):6923-6932. doi: 10.1002/cam4.2517. Epub 2019 Sep 30. Cancer Med. 2019. PMID: 31568698 Free PMC article. Clinical Trial.
An integrated approach to cardioprotection in lymphomas.
Maraldo MV, Levis M, Andreis A, Armenian S, Bates J, Brady J, Ghigo A, Lyon AR, Manisty C, Ricardi U, Aznar MC, Filippi AR. Maraldo MV, et al. Lancet Haematol. 2022 Jun;9(6):e445-e454. doi: 10.1016/S2352-3026(22)00082-5. Epub 2022 May 2. Lancet Haematol. 2022. PMID: 35512725 Review.
Editorial: Imaging assessment of response to immunotherapy.
Occhipinti M, Filippi AR, Walsh S, van Meerbeeck JP. Occhipinti M, et al. Among authors: filippi ar. Front Oncol. 2023 Jan 20;12:1116315. doi: 10.3389/fonc.2022.1116315. eCollection 2022. Front Oncol. 2023. PMID: 36741725 Free PMC article. No abstract available.
Treatment of metastatic melanoma: a multidisciplinary approach.
Fava P, Astrua C, Sanlorenzo M, Ribero S, Brizio M, Filippi AR, Marra E, Picciotto F, Sangiolo D, Carnevale-Schianca F, Aglietta M, Sandrucci S, Ricardi U, Caliendo V, Quaglino P, Fierro MT. Fava P, et al. Among authors: filippi ar. G Ital Dermatol Venereol. 2017 Jun;152(3):241-261. doi: 10.23736/S0392-0488.17.05633-4. Epub 2017 Mar 14. G Ital Dermatol Venereol. 2017. PMID: 28290625 Review.
New options and open issues in the management of unresectable stage III and in early-stage NSCLC: A report from an expert panel of Italian medical and radiation oncologists - INTERACTION group.
Catania C, Filippi AR, Sangalli C, Piperno G, Russano M, Greco C, Scotti V, Proto C, Bennati C, Di Pietro Paolo M, Platania A, Olmetto E, Agustoni F, Teodorani N, Agbaje V, Russo A. Catania C, et al. Crit Rev Oncol Hematol. 2023 Oct;190:104108. doi: 10.1016/j.critrevonc.2023.104108. Epub 2023 Aug 24. Crit Rev Oncol Hematol. 2023. PMID: 37633350 Review.
Radiation therapy for older patients with brain tumors.
Minniti G, Filippi AR, Osti MF, Ricardi U. Minniti G, et al. Radiat Oncol. 2017 Jun 19;12(1):101. doi: 10.1186/s13014-017-0841-9. Radiat Oncol. 2017. PMID: 28629376 Free PMC article. Review.
Radiomics features as predictive and prognostic biomarkers in NSCLC.
Bortolotto C, Lancia A, Stelitano C, Montesano M, Merizzoli E, Agustoni F, Stella G, Preda L, Filippi AR. Bortolotto C, et al. Expert Rev Anticancer Ther. 2021 Mar;21(3):257-266. doi: 10.1080/14737140.2021.1852935. Epub 2020 Dec 4. Expert Rev Anticancer Ther. 2021. PMID: 33216651 Review.
152 results